The Broad Institute of MIT is making a substantial investment with 51 of the devices. It was just a couple years ago that prices on the sequencing machines were
really expensive, and well they still are not cheap, but a lot more affordable than at that time.
Just a couple weeks ago the FDA cleared the new genomic test for thrombosis, done with an Illumina machine and their VeraCode technology. BD
FDA Clears Genomic Test for Thrombosis
From the Illumina Website:
With innovative design features, HiSeq 2000 is the easiest to use next-generation sequencing system.
- Flow cells are easily loaded on the vacuum-controlled loading dock.
- Pre-configured, plug-and-play reagents sufficient for up to 200 cycles drop into racks in the machine's chiller compartment, requiring only two minutes of hands-on time.
- A simple touch screen user interface, including on-screen, step-by-step instructions with embedded multimedia help, simplifies run setup.
- Real-time progress indicators provide at-a-glance status, and remote monitoring allows a single user to check progress on multiple systems from any browser or internet-enabled phone.
- HiSeq 2000 can be operated in single or dual flow cell mode, offering unmatched experimental flexibility and instrument scalability.
- Independently-operable flow cells allow applications requiring different read lengths to run simultaneously.
- Illumina's efficient and scalable data analysis solution for transforming billions of bases of raw sequencing data into publishable, biologically meaningful
results is included.
In a single run, sequence two human genomes at ~30x coverage for less than $10,000 (USD) per genome, or perform 200 gene expression profiles for less than $200 per sample.
NEW YORK (GenomeWeb News) – The Broad Institute has purchased 51 HiSeq 2000 instruments from Illumina.
The HiSeq 2000 was launched earlier this year and is the latest version of Illumina's sequencing technology, providing a variety of upgraded features over its Genome Analyzer. At the time of its launch, the firm announced that Chinese genome center BGI had ordered 128 of the new systems.
Illumina said that the HiSeq instruments will replace an equal number of Genome AnalyzerIIx systems at the Broad as the institute upgrades and expands its sequencing capacity. Illumina added that it expects to ship the systems to the Broad over the next several quarters.
0 comments :
Post a Comment